NEW YORK, NY / ACCESS Newswire / March 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...
NEW YORK CITY, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...
March 11 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid ...
The decision made public on Tuesday by U.S. District Judge Kenneth Bell in Charlotte, North Carolina covers more than 200 ...
Merck & Co's efforts to diversify its cancer pipeline beyond immunotherapy blockbuster Keytruda have taken a big step forward with a wide-ranging alliance with China's Kelun-Biotech that spans ...
Merck is taking an exclusive commercial license to the drug – called pimicotinib (ABSK021) – in China, Hong Kong, Macau, and Taiwan, with an option on rights for the rest of the world.
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other best pharma stocks to buy according to hedge funds. Why is China the Talk of the Town ...
Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...
Chalinee Thirasupa/ Reuters In February 2025, China expanded its influence in the Indo-Pacific through diplomatic outreach, infrastructure investment, and coordinated security efforts—hosting ...
Consumer prices in China have plunged to their lowest level in more than a year, highlighting persistent deflationary pressures in the world’s second-largest economy. The Consumer Price Index ...